• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Influenza Vaccination Reduces Hemorrhagic Stroke Risk in Patients With Atrial Fibrillation: A Population-Based Cohort Study
In this study, we investigated the association of influenza vaccination with the risk of hemorrhagic stroke to develop an efficient strategy for reducing this risk in patients with AF.
Source: International Journal of Cardiology - December 21, 2016 Category: Cardiology Authors: Ju-Chi Liu, Yi-Ping Hsu, Szu-Yuan Wu Source Type: research

Protective effect of influenza vaccination on outcomes in geriatric stroke patients: A nationwide matched cohort study
The effects of influenza vaccination (IV) on stroke outcomes are unclear. The purpose of this study is to evaluate the outcomes after stroke in elderly individuals who have received an IV.
Source: Atherosclerosis - January 26, 2019 Category: Cardiology Authors: Fai Lam, Ta-Liang Chen, Chun-Chuan Shih, Chao-Shun Lin, Chun-Chieh Yeh, Yuarn-Jang Lee, Chaur-Jong Hu, Hung-Yi Chiou, Chien-Chang Liao Source Type: research

Higher Stroke Rate in COVID-19 vs Influenza Higher Stroke Rate in COVID-19 vs Influenza
New study provides further support for as well as more insight on stroke risk associated with COVID-19.Medscape Medical News
Source: Medscape Cardiology Headlines - July 7, 2020 Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news

Flu Shots Tied to Lower Stroke Risk
(MedPage Today) -- Annual flu shots were tied to lower ischemic stroke risk, a case-control study in Spain showed. Older adults who received an influenza vaccine were 12% less likely to have an ischemic stroke versus people who weren't vaccinated...
Source: MedPage Today Cardiovascular - September 7, 2022 Category: Cardiology Source Type: news

Beneficial Effects of Vaccination on Cardiovascular Events: Myocardial Infarction, Stroke, Heart Failure
Influenza and pneumococcal infections have been suggested to be potential risk factors for causing adverse cardiovascular events, especially in high-risk patients. Vaccination against respiratory infections in patients with established cardiovascular disease (CVD) could serve as a potential cost-effective intervention to improve their clinical outcomes and cardiac societies have encouraged it. Previous studies have shown that influenza vaccination reduce mortality, acute coronary syndromes and hospitalization in patients with coronary heart disease (CHD) and/or heart failure (HF). However, there is a paucity of randomized ...
Source: Cardiology - November 15, 2018 Category: Cardiology Source Type: research

Association between Influenza Vaccination and Reduced Risks of Major Adverse Cardiovascular Events in Elderly Patients
Conclusions Results of this study suggest that influenza vaccination is associated with reduced primary MACE risks in the elderly population, including those with ILI.
Source: American Heart Journal - August 2, 2017 Category: Cardiology Source Type: research

Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands
ConclusionScreening for AF in primary care with a handheld, single-lead ECG during seasonal influenza vaccination is very likely to be cost saving for identifying new cases of AF in the Dutch population aged 65 years and over. Active screening for AF with a single-lead, handheld ECG device during seasonal influenza vaccination could be implemented in primary care.
Source: Europace - October 11, 2016 Category: Cardiology Source Type: research

Correlation Between Cardiovascular Protection and Influenza Vaccination
AbstractPurpose of ReviewInfluenza is the cause of millions of deaths yearly in the USA and globally. It presents a significant health burden in millions of people and is associated with chronic disease exacerbations including acute cardiovascular events such as myocardial infarction and stroke. We reviewed recent studies and a meta-analysis to assess the part that influenza vaccination plays in cardiovascular system protection.Recent FindingsA sizable study measured the effect of influenza vaccination on cardiovascular health and mortality. This retrospective observational study used the 2012 –2015 US National Inpatient...
Source: Current Cardiology Reports - April 14, 2023 Category: Cardiology Source Type: research

Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation
Conclusion The high AF detection performance of the MyDiagnostick, combined with the ease of use of the device, enables large screening programmes for detection of undiagnosed AF.
Source: Europace - August 29, 2014 Category: Cardiology Authors: Tieleman, R. G., Plantinga, Y., Rinkes, D., Bartels, G. L., Posma, J. L., Cator, R., Hofman, C., Houben, R. P. Tags: Atrial fibrillation Source Type: research

Randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events (IVVE): Rationale and design
ConclusionThis is the largest randomized trial to test if influenza vaccine compared to control reduces adverse vascular events in high risk individuals.Trial registration number:Clinicaltrials.govNCT02762851
Source: American Heart Journal - March 12, 2019 Category: Cardiology Source Type: research

Cardiac myxomas: clinical presentation, diagnosis and management
Cardiac myxomas (CM) are the most common type of primary cardiac tumours in adults, which have an approximate incidence of up to 0.2% in some autopsy series. The purpose of this review is to summarise the literature on CM, including clinical presentation, differential diagnosis, work-up including imaging modalities and histopathology, management, and prognosis. CM are benign neoplasms developed from multipotent mesenchyme and usually present as an undifferentiated atrial mass. They are typically pedunculated and attached at the fossa ovalis, on the left side of the atrial septum. Potentially life-threatening, the presence ...
Source: Heart - May 12, 2022 Category: Cardiology Authors: Griborio-Guzman, A. G., Aseyev, O. I., Shah, H., Sadreddini, M. Tags: Review articles Reviews Source Type: research

Arterial Thrombotic Events in Hospitalized COVID-19 Patients: A Short Review and Meta-Analysis
In conclusion, we found a non-negligible proportion of ATE in patients hospitalized for COVID-19. Our results are similar to those found in hospitalized patients with influenza or with non-COVID viral pneumonia.PMID:35793687 | DOI:10.1055/s-0042-1749661
Source: Atherosclerosis - July 6, 2022 Category: Cardiology Authors: Matteo Candeloro Sam Schulman Source Type: research

Influenza vaccination and cardiovascular events in patients with ischaemic heart disease and heart failure: A meta ‐analysis
ConclusionIn this meta-analysis of available RCTs in patients at high cardiovascular risk, influenza vaccination was associated with a reduced incidence of cardiovascular events, cardiovascular death and all-cause death as compared to placebo or no treatment.
Source: European Journal of Heart Failure - June 28, 2023 Category: Cardiology Authors: Daniel Modin, Mats Christian H øjbjerg Lassen, Brian Claggett, Niklas Dyrby Johansen, Maryam Keshtkar‐Jahromi, Kristoffer Grundtvig Skaarup, Joshua Nealon, Jacob A. Udell, Orly Vardeny, Scott D. Solomon, Gunnar Gislason, Tor Biering‐Søren Tags: Research Article Source Type: research